Skip to content
  • Resources

Hemophilia Treatment Centers

Many people with bleeding disorders use the resources of their hemophilia treatment center (HTC). Individuals who go to hemophilia treatment centers will not only find state-of-the art medical care, but also benefit from an experienced, caring staff that takes time to develop comprehensive treatment care plans for patients and families. Local Hemophilia Treatment Centers:
  • Gulf States Hemophilia & Thrombophilia Center 7000 Fannin, Suite 750 Houston, TX 77030 Phone: 713-500-8360
  • Texas Children’s Hemophilia & Thrombosis Center 6701 Fannin Street Suite 1580 Houston, Texas 77030 Phone: 832-822-4362
  • Children’s Blood and Cancer Center of Central Texas – Dell Children’s Specialty Pavillion 4910 Mueller Blvd Ste 200 Austin, TX 78723 Phone: 512-628-1900
  • South Texas Hemophilia Treatment Center Gateway Medical Park
  • 8435 Wurzbach Road San Antonio, TX 78229 Phone: 210-332-0661

Assistance Programs

Your Social Worker at your Hemophilia Treatment Center can help you navigate resources for financial assistance. Please contact your Social Worker for a LSBDF Helping Hands referral application.

Hemophilia Assistance Program

Website- Hemophilia Assistance Program The Hemophilia Assistance Program helps Texans with hemophilia cover their medical bills. Assistance is provided with blood factor replacement products or reimbursement for health insurance premium payment. Who is eligible for services? HAP is available to anyone who
  • Lives in Texas
  • Is 18 or older
  • Has an income at or below 200 percent of federal poverty guidelines
  • Has a diagnosis of hemophilia from a licensed physician
  • Isn’t incarcerated or a ward of the state
  • Isn’t eligible for the Children with Special Health Care Needs Services Program, Medicaid or Medicare

PAN Foundation

https://www.panfoundation.org

News from HFA

  • Scholarship Recipient: Michael Potanin

    2023 HFA Educational Scholarship Johns Hopkins University, Maryland I am honored to have been chosen as a recipient of the HFA Educational Scholarship. This recognition provides immense support to me as I pursue my education and career goals. As a hemophiliac who has personally experienced the challenges of living with a genetic disorder, I am The post Scholarship Recipient: Michael Potanin appeared first on Hemophilia Federation of America.

  • Scholarship Recipient: Porus Pavri

    2023 HFA Educational Scholarship Rutgers University, New Jersey As an individual with hemophilia, my journey has been shaped by both challenges and determination. These experiences have propelled me towards pursuing a business major and setting ambitious future goals. I believe that the intersection of my personal circumstances and academic aspirations is a unique space where The post Scholarship Recipient: Porus Pavri appeared first on Hemophilia Federation of America.

  • Blog: Random Thoughts from a Venerable Hemophiliac 

    At 73 and retired, I can look back on life, and wonder how I got to where I am.  Seventy-three is old. You appreciate social security, Medicare, pensions, and the occasional days where arthritis isn’t winning the joint battle.  You appreciate your high school girlfriend who became your wife of 52 years, your adult sons and The post Blog: Random Thoughts from a Venerable Hemophiliac  appeared first on Hemophilia Federation of America.

  • Novo Nordisk Announces Supply Shortage

    Novo Nordisk today announced an important update about the Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated 3000 IU vial size.  From Novo Nordisk: In May 2023, Novo Nordisk launched the Rebinyn® 3000 IU vial size, and the demand for this vial size has outpaced our expectations. This has resulted in a temporary shortage that will lead The post Novo Nordisk Announces Supply Shortage appeared first on Hemophilia Federation of America.

  • Word from Washington: January 2024

    On January 16, the U.S. Department of Health and Human Services withdrew its appeal in the litigation over HHS’s copay accumulator adjuster regulation. Patient groups including HFA applauded this latest development in the lawsuit.  As a reminder, patient groups led by the HIV + Hepatitis Policy Institute had filed suit against HHS, challenging its 2021 The post Word from Washington: January 2024 appeared first on Hemophilia Federation of America.